American Well Co. (NYSE:AMWL) Given Consensus Recommendation of “Hold” by Analysts

American Well Co. (NYSE:AMWL) has been given an average rating of “Hold” by the six brokerages that are covering the stock, Marketbeat reports. Five investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $11.90.

A number of equities analysts have weighed in on AMWL shares. Stifel Nicolaus upped their price target on shares of American Well from $9.00 to $10.00 and gave the stock a “hold” rating in a research report on Thursday, February 13th. Morgan Stanley dropped their target price on shares of American Well from $20.00 to $10.50 and set an “equal weight” rating for the company in a report on Tuesday, December 17th. Wells Fargo & Company raised American Well from an “equal weight” rating to an “overweight” rating and set a $15.00 price target on the stock in a report on Monday, January 13th. Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a research note on Thursday, February 13th. Finally, Truist Financial lifted their target price on American Well from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, February 14th.

American Well Stock Performance

Shares of American Well stock opened at $6.59 on Friday. The stock has a market cap of $102.87 million, a P/E ratio of -0.47 and a beta of 1.22. The stock’s fifty day moving average is $9.59 and its 200 day moving average is $9.24. American Well has a one year low of $5.00 and a one year high of $15.88.

American Well (NYSE:AMWL) last posted its quarterly earnings data on Wednesday, February 12th. The company reported ($2.77) EPS for the quarter, topping the consensus estimate of ($3.04) by $0.27. American Well had a negative return on equity of 56.73% and a negative net margin of 81.83%. Analysts predict that American Well will post -9.34 EPS for the current year.

Insider Buying and Selling

In related news, insider Phyllis Gotlib sold 4,781 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $8.80, for a total value of $42,072.80. Following the sale, the insider now owns 147,998 shares in the company, valued at approximately $1,302,382.40. The trade was a 3.13 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Over the last three months, insiders have sold 5,219 shares of company stock worth $46,454. Corporate insiders own 12.80% of the company’s stock.

Institutional Trading of American Well

A number of large investors have recently made changes to their positions in the business. 4D Advisors LLC purchased a new position in shares of American Well in the 4th quarter worth approximately $1,088,000. Takeda Pharmaceutical Co. Ltd. bought a new position in American Well during the fourth quarter valued at $564,000. Senvest Management LLC raised its stake in shares of American Well by 3.9% in the fourth quarter. Senvest Management LLC now owns 1,300,611 shares of the company’s stock valued at $9,429,000 after acquiring an additional 48,800 shares during the period. HighTower Advisors LLC bought a new stake in shares of American Well in the 3rd quarter worth about $355,000. Finally, Norges Bank purchased a new position in shares of American Well during the 4th quarter worth about $204,000. 56.05% of the stock is currently owned by institutional investors.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.